Gamma-vinyl GABA.
Hammond
E J
EJ
Wilder
B J
BJ
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000596:Amino Acids / Q000378:metabolism; D000614:Aminocaproates / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects*; D002319:Cardiovascular System / Q000187:drug effects; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D010907:Pituitary Hormones / Q000378:metabolism; D012640:Seizures / Q000139:chemically induced; D014617:Vacuoles / Q000187:drug effects; D020888:Vigabatrin; D015091:beta-Alanine / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism / Q000502:physiology
D000596:Amino Acids; D000614:Aminocaproates; D010907:Pituitary Hormones; D015091:beta-Alanine; D005680:gamma-Aminobutyric Acid; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin